Related by context. All words. (Click for frequent words.) 67 Jumps Higher 67 Q2 Adj 66 Q1 Profit Surges 66 Q4 Loss Narrows 66 Q2 Profit Surges 66 Sinks Lower 65 Q1 Loss Narrows 64 Q3 Loss Narrows 64 Bearish MACD 64 Q2 Loss Narrows 64 Q3 Loss Widens 63 Q1 Adj 63 Q1 Profit Plunges 63 Q3 Adj 63 Q4 Loss Widens 63 Welcomes Analyst Initiation 63 Q2 Loss Widens 63 Earnings Postmortem 62 Q1 Loss Widens 62 Q2 Profit Soars 62 Posts Wider Loss 62 Terminate Merger Agreement 62 Coverage Initiated 62 Regains NASDAQ 62 Q4 Adj 62 Q1 Profit Soars 62 Exploring Strategic Alternatives 61 1Q Loss Widens 61 Net Loss Narrows 61 Q1 Profit Declines 61 Files Shelf Registration Statement 61 Stockholders Approve Acquisition 61 Posts Narrower Loss 61 Proposed Buyout 61 Q3 Profit Soars 61 Boosts Quarterly Dividend 61 Momenta Pharmaceuticals MNTA 60 Posts Wider 60 Bearish Pressure Building 60 Explore Strategic Alternatives 60 Amends Agreement 60 COO Exercises Options 60 Endures Analyst Downgrade 60 Shareholders Approve Acquisition 60 Boosts Guidance 60 Regains Full 60 Completes Merger With 60 Announces Organizational Changes 60 ADRX 60 Board Authorizes 60 3Q Loss Widens 60 Explores Strategic Alternatives 60 Boosts Outlook 60 Attracting Bullish Investors 60 PROFILE CO 60 Approaching Resistance 60 Movers Roundup 60 Receives NASDAQ 60 Sentiment Snapshot 60 2Q Loss Widens 60 Aftermarket Movers 60 Board Unanimously Rejects 60 Reports Narrower 60 Remains Neutral 59 Successfully Completes Tender Offer 59 Premarket Movers 59 Shareholder Lawsuit Against 59 Reports Wider Loss 59 CEO Exercises Options 59 Receives Favorable 59 narrows Quick Facts 59 SWOT Analysis Aarkstore Enterprise 59 Net Loss Widens 59 Posts 4Q Profit 59 Boosts Buyback 59 Initiates Clinical Trial 59 Suspends Dividend 59 Movers roundup 59 Raises Buyback 58 Wolf Haldenstein Investigating 58 Therapeutic Competitors companiesandmarkets.com adEgemonye 58 FY# Loss Narrows 58 Posts Wider 4Q Loss 58 Narrows Loss 58 Plans Buyback 58 Declares Quarterly Dividends 58 3Q Loss Narrows 58 Begins Dosing 58 Evaluate Strategic Alternatives 58 SVP Exercises Options 58 Q2 Quick Facts 58 Receives Clearance From 58 Stockholders Approve Merger Agreement 58 Receives Clearance 58 Posts 2Q 58 Posts 1Q 58 Files Annual Report 58 Q4 Profit Drops 58 Commenced Against 58 widens Quick Facts 58 Regains Nasdaq 58 Posts 4Q 58 2Q Loss Narrows 58 Has Re Crossed 58 Files Shelf Registration 58 Earnings Disappoint 58 Posts Narrower 58 Cuts FY# 57 Hold Third Quarter 57 Reminds Shareholders 57 Posts 4Q Loss 57 Premarket Roundup 57 Sets Second Quarter 57 Senior VP Exercises 57 Narrows 4Q Loss 57 Q4 Profit Plummets 57 Approve Acquisition 57 CTRX 57 Begins Tender Offer 57 Posts Smaller 57 ZACKS.COM 57 OKs Buyback 57 Bullish Engulfing Formed 57 Sells Shares 57 Announces Discontinuation 57 Posts Wider Than Expected 57 Posts 2Q Loss 57 Initiates Enrollment 57 Files Investigational 57 Completes Previously Announced 57 Guides Q4 57 Reports Narrower Loss 56 FY# Quick Facts 56 Beats Estimates Analyst Blog 56 Stays Neutral 56 Announces Presentation 56 Registration Statement Declared Effective 56 2Q Loss 56 Q3 Quick Facts 56 IG HCR ;) CO 56 ValuEngine Upgrades 56 Delivers Solid 56 Reveals Resignation Of 56 Announce Expiration 56 SWOT Analysis http:/www.companiesandmarkets.com aJEH MacDonald 56 Quarterly Loss Narrows 56 Q1 Quick Facts 56 Adopts Stockholder Rights 56 Nasdaq ANPI 56 Raises Quarterly Dividend 56 Sees 2Q 56 Posts 3Q 56 Completes Recapitalization 56 4Q Loss 56 Signs Definitive Merger Agreement 56 Extends Expiration Date 56 Discusses Q4 55 Investigates Proposed Acquisition 55 Narrows 1Q 55 Reports Wider 55 Declares Preferred 55 Backs FY# 55 Receives Orphan Drug Designation 55 NASDAQ NRGN 55 Third Quarter Loss Widens 55 Lowers 1Q 55 Receives Approvable Letter 55 Announces Repurchase 55 Provides Status 55 Receives Subpoena 55 2Q Profit Doubles 55 Submits Response 55 AUDIO PROVIDED BY 55 Candlesticks Bearish Engulfing 55 Lowers 3Q 55 Loss Shrinks 55 Holds Annual Meeting 55 Reschedules Fourth Quarter 55 Schedules Investor 55 Completes Redemption 55 Completes Tender Offer 55 adopts poison pill 55 Withdraws Proposal 55 Narrows 2Q 55 Webcast Annual Meeting 55 Urges Shareholders 55 MDTH 54 Inc. NASDAQ CVTX 54 RTTNews Biopharmaceutical 54 Nasdaq IDIX 54 Announce Initiation 54 Posts 3Q Loss 54 Completes Buyout 54 Expects 3Q 54 Losses Narrow 54 Confirms Commitment 54 narrows 1Q loss 54 Premarket roundup 54 Inc POZN 54 Expects 1Q 54 Loss Narrows 54 Reports 4Q Loss 54 Inc. Attracting Bullish 54 HOT STOCKS 54 Biggest laggers 54 Reaches Tentative Settlement 54 Quarterly Loss Widens 54 Reaffirms FY# 54 Sees 3Q 54 Completes Spin Off 54 Declines Quick Facts 54 Beats Expectations 54 Discusses Q3 54 Granted Early Termination 54 CONFERENCE CALLS SOURCE 54 Adopts Poison Pill 54 Nasdaq PGNX 54 RESEARCH ALERT Jefferies 54 MSLP.OB 54 Expects 4Q 54 Posts Wider 2Q 54 posts 4th qtr 54 Q1 adj 53 Enrolls First 53 NADX 53 1Q Loss 53 Co. Initiates Independent 53 Investigates Buyout 53 NASDAQ IDIX 53 Reacquires 53 Myrexis Inc. 53 Appoints Experienced 53 Analysts Upgrades Downgrades 53 earns rev 53 Restate Earnings 53 Revises Q3 53 Restates Earnings 53 SLTM 53 Announces Departure 53 Completes Issuance 53 NASDAQ ADLR 53 Shareholders Elect 53 Completes Debt Refinancing 53 Announces Recapitalization 53 Loss Widens 52 Analyst downgrades 52 CFO resigns 52 Enzon Pharma 52 Sees 4Q 52 Loss Reduces 52 BIOTECH STOCKS 52 Reports Wider Than 52 narrows 4Q loss 52 Begins Clinical Trial 52 Postpones Annual Meeting 52 Subsidiary Files 52 Inc.David 52 Q2 adj 52 Rejects Buyout Offer 52 Sees 1Q Profit 52 First Patient Enrolled 52 1Q Profit Tumbles 52 Narrows 3Q 51 Gets Subpoena 51 Inc. NASDAQ EVVV 51 Trims Guidance 51 Fraud Suit Against 51 Mails Letter 51 NASDAQ MDVN 51 Sees 1Q 51 narrows 3Q loss 51 Posts Fourth Quarter 51 Posts Higher 51 Earnings roundup 51 Lowers FY# 51 Inc. Nasdaq TRMS 51 posts 3rd qtr 51 From Cont 51 BANKING SOURCE 51 Amends Existing 51 Inc.John 51 Inc CEPH 51 Nasdaq GENR 51 FFO Declines 51 Sanofi NYSE SNY 51 Secures Long Term 51 Initiates Quarterly 51 reaffirms FY# 50 Resigns Quick Facts 50 Q3 adj 50 Submits Revised 50 Backs FY# Adj 50 Hires Experienced 50 narrows 2Q 50 Q4 adj 50 shuffles execs 50 CALLS EARNINGS SOURCE 50 Nasdaq BPUR 50 ILEX Oncology 50 CALLS SOURCE 50 CORRECTED BRIEF 50 Inc.Media Contact 50 Explores Sale 50 Tops Ests 50 Exercises Options 50 Sees Q1 50 Concerning Acquisition 50 Misled Investors 50 Files Restated 50 narrows 3Q 50 WeissComm Partners +#-#-#-# 50 Sells Portion 50 revises 4Q 50 Inc.Investor 50 RESEARCH ALERT UBS 50 EPS Excl 50 BIOTECHNOLOGY SOURCE 50 Catalyst Biosciences 50 Web Site http:/www.cryolife.com 50 KSF encourages both 50 Appoints Interim 50 Shareholders Approve Buyout 49 NASDAQ AFFY 49 NASDAQ BMRN 49 operating subsidiary CytoSorbents 49 OMRIX Biopharmaceuticals 49 PXSL 49 Inc NGSX 49 Javelin Pharmaceuticals Inc 49 3Q earns 49 Optimer Pharma 49 Reduces Quick Facts 49 posts 1st qtr 49 Kelly Luethje #-#-# 49 Sees Q3 49 Announces Resignation 49 Cellegy Pharmaceuticals 49 Sees Q2 49 Inc.Investor Relations 49 Inc. Nasdaq MYOG 49 Reaches Agreements 49 Lowers 2Q 49 Enzon Pharmaceuticals Inc 49 NASDAQ CGPI 49 Debt Rtgs Mgrs Priced 49 EARNINGS SOURCE 49 CorporationInvestor 49 Subsidiaries Condensed Consolidated 49 RESEARCH ALERT JP Morgan 48 Chemokine Therapeutics Corp. 48 4Q Profit Tops 48 Covalon Technologies 48 Inc CYBX 48 NTMD 48 Sees Q4 48 outlook disappoints 48 Revises 48 Inc. http:/www.endocare.com 48 posts 2nd qtr 48 Jon Kamp 48 lifts FY# EPS 48 Subsidiaries Supplemental Non GAAP 48 Shuffles Executives 48 Financial Officer# 48 X Ceptor Therapeutics 48 Adopts Rule #b# 48 NASDAQ APPX 48 Drew Fromkin President 48 Posts Wider 3Q 48 NASDAQ IDEV 48 Inc.Investor Contact 47 MISYS PLC 47 Inc. Nasdaq COLY 47 RESEARCH ALERT 47 PRN CORRECTION 47 P. Luci 47 lowers FY# EPS 47 PRICED * 47 Inc.Investors 47 GendeLLindheim BioCom Partners 47 CAMBRIDGE Mass. Biotechnology 47 website www.celsion.com 47 ReAble Therapeutics 47 revises FY# 47 Hakan Edstrom 47 LLP Investigates 47 Accepts Resignation 47 Praecis Pharmaceuticals 47 RPT CORRECTED 47 ENERGY OIL GAS 47 qtrly profit 47 NASDAQ ACOR 47 NASDAQ TTHI 47 Settles Shareholder Lawsuit 47 Inc.Michael 47 Appointed Interim 47 ALSO NOTED 47 Inc.Mark 47 Option Skews 47 Renews Relationship 47 BIOTECH STOCKS Drug 47 NYSE SGP 47 Expects 2Q 47 Erinn B. Broshko 47 Nasdaq MDCO 47 FPIC Insurance 47 Mpex Pharmaceuticals 46 please visit http:/www.astrazeneca-us.com 46 Makes Announcement 46 CBNK 46 Holdings Liquidated 46 www.vivus.com 46 NV OFIX 46 MEDICAL PHARMACEUTICAL 46 Advancis Pharmaceutical Corporation 46 CONTACT ICR 46 Nasdaq ADLR 46 operates CTS Teleradiology 46 Hold Teleconference 46 Nasdaq MOGN 46 Renews Lease 46 PFIZER INC. 46 Peggy Pinkston 46 Gary Restani 46 RESEARCH ALERT BofA 46 Named Successor 46 Posts Wider 1Q 46 Posts 4th Qtr 46 JJ Finkelstein 46 Earns Accreditation 46 RESEARCH ALERT Deutsche 46 Inc Erngs Conf Call 46 reiterates FY 45 Corp. BVF.TO Quote 45 Inc. OTCBB SPRX 45 CT Kontakt 45 RESEARCH ALERT Merrill 45 Cerus Corporation 45 NASDAQ POZN 45 Greg Geissman 45 OTCBB CONX 45 Retains OTC 45 NASDAQ BSMD medical 45 Nasdaq RIGL 45 3rd qtr profit 45 PSI NASDAQ PSYS 45 boosts 1Q 45 Causes Shareholder 45 INDUSTRY KEYWORD BANKING SOURCE 45 Chief Financial Officer# 45 RESEARCH ALERT Prudential 45 4th qtr profit 45 Nucryst Pharmaceuticals 45 NASDAQ MOGN 45 Widens 1Q 45 Georges Gemayel 45 Re Elects 45 Eric Brielmann 45 Juergen Engel 45 Tiberend Strategic Advisors 45 Spiro Rombotis 45 Nasdaq SPNC 45 PHMD 45 qtly 45 Shering Plough 45 sees FY opg 45 Sheryl Seapy 45 RESEARCH ALERT Morgan Stanley 45 QLT CN 45 Reaches Settlement With 45 RESEARCH ALERT Lehman 45 Adeza Biomedical Corporation 45 Ventures MPM Capital 45 Opko Health Inc. 45 Adds Seasoned 44 Mark Sirgo 44 Becton Dickinson BD 44 Inc.Robert 44 q2 44 John F. Thero 44 Alleges Fraud 44 G. Mason Morfit 44 Corp. MDTH 44 INVESTOR CONTACTS 44 RESEARCH ALERT Credit Suisse 44 SafeStitch Medical 44 Widens 44 OFFICIAL CORRECTION 44 CONTACT Cyclacel Pharmaceuticals 44 Craig Tooman 44 Maurizio Vecchione 44 +#-#-#-# Ext [001] 44 Arcus Ventures 44 Transition Therapeutics Inc 44 RESEARCH ALERT Goldman 44 Valera Pharmaceuticals 44 Inc.Media 44 NASDAQ BSMD 44 Akzo Organon 44 AMLN.O Quote Profile Research 44 al@cameronassoc.com 44 SCHEDULED TO PREMIERE 44 http:/www.viropharma.com 44 Logo SOURCE 44 1st qtr profit 44 Assumes Role 44 posts 1Q 44 RPT UPDATE 1 44 Raven biotechnologies 44 Euroshares outlook higher 44 pares losses 44 Connectyx Announces 44 Corp SYY 44 NEC Elec 43 adj Q3 43 http:/www.amgen.com 43 Amedisys Inc 43 CORRECTION CORRECTED 43 NASDAQ MDAS 43 Carl Spana Ph.D. 43 CORRECTED OFFICIAL UPDATE 43 SYSTEMS CORPORATION 43 Eric Bjerkholt 43 DukeNet Communications 43 NovoNordisk 43 Staar Surgical 43 qtly profit 43 Hugues de Bantel 43 cont ops 43 REFILE US 43 Q3 opg 43 Uli Hacksell Ph.D. 43 Steven Kriegsman 43 Nicole Foderaro 43 Hovnanian trims 43 UNH #/#/# PriceWatch 43 Q1 opg 43 Jeffrey Buchalter 43 Patrick Fourteau 43 Resale Registration Statement 43 Kaplow Communications 43 Inc. OTCBB CYKN 43 Masimo Corporation 43 Andrew Makrides 43 Earnings Preview Activision Blizzard 43 Reduces 43 Valera Pharmaceuticals Inc. 43 narrows 4th qtr 42 Sees FY 42 M.D. Joins 42 yr BAS 42 InKine Pharmaceutical Company 42 Penwest Pharmaceuticals 42 Nasdaq MDTH 42 Yoshihiko Hatanaka 42 CORRECTED OFFICIAL 42 SNAPSHOT US 42 Contacts Lippert Heilshorn 42 Sees FY# 42 2nd qtr profit 42 Inc. Nasdaq RNVS 42 H1 pretax loss 42 Igor Gonda 42 STOCKS NEWS US 42 Don deBethizy 42 MacDougall Biomedical Communications 42 Nancy Wysenski 42 STOCKS Futures slip 42 posts 2Q 42 S. Scibetta 42 REFILE UPDATE 1 42 BRIEF 42 NA BARC 42 CONTACT Investor Relations 42 Q2 opg 42 EARNINGS POLL 42 Zars Pharma 42 2d qtr 42 Corp. Nasdaq MEMY 42 Ltd. Bill Trenaman 42 William Rastetter 41 Stephen Gendel 41 www.mannatech.com 41 Slips 41 COMPANY CONTACT 41 Alan R. Engbring 41 CancerVax Corporation 41 Elkan Gamzu Ph.D. 41 posts 3Q 41 www.spacenet.com 41 Nisource 41 www.angiotech.com 41 www.endocare.com 41 Narrowed 41 IPO VIEW 41 adj Q4 41 Fleishman Hillard +#-#-#-# 41 UPDATE1 41 Glenn Schulman Pharm.D 41 Bernd Seizinger 41 Ina Cu 41 Earnings Preview Bristol Myers 41 Genaera Liquidating Trust 41 #Chief Financial 41 Adolor Corporation 41 BRUCE WATSON Posted 41 #Executive Vice President 41 +#-#-#-# x# [003] 41 Richard Faleschini 41 Prosidion 41 Roland Haefeli 41 Rod Shier 41 Carl Spana 41 Duska Therapeutics Inc. 41 CorporateCommunications +#-#-#-# 41 Q4 revs 41 Investor Inquiries 41 #Chief Financial Officer 41 Inc.William 41 shrs 41 Barbara Lindheim 41 William Craumer 41 Michael N. Kilpatric 40 http:/www.pharmacopeia.com 40 CORRECTION 40 NASDAQ BSMD BioSphere 40 Cipher Pharmaceuticals 40 Drugmaker Elan 40 #Sr 40 Trims 40 posts 4Q 40 ParaPRO 40 InvestorRelations +#-#-#-# 40 Wayne T. Hockmeyer 40 @ bms.com 40 +#-#-#-# Fax +#-#-#-# [002] 40 STOCKWATCH 40 FY# adj 40 Sheldon Berkle 40 #-#-# @ bms.com 40 Corporate Communications# 40 TechMARK movers 40 #-#-# KEYWORD PENNSYLVANIA 40 D. Joseph Gersuk 40 CMX.N 40 PhD RPh 40 Caroline Loewy 40 MIDDAY BUSINESS REPORT 40 Biopure Corporation 40 Anne Pearson apearson@drg-e.com 40 Orville Kolterman 40 misses f'cast 40 KEYWORD MEDICAL 40 Joanna Horobin MD 40 Dave Holveck 40 IDEC Pharmaceuticals Corporation 40 Bibicoff + MacInnis 40 Adjusts 40 Cosmetic Essence 40 Nasdaq INSU 40 CORRECTED CORRECTED UPDATE 40 1Q profit 40 Inc RX.N 40 @ newmont.com 40 Lisa Krinsky 40 Bradley Sheares 40 Robert Gruder 40 Euroshares outlook lower 40 #Vice 40 Fabre Kramer 40 John R. Plachetka 40 Ernie Knewitz 40 Ludo Reynders 40 #Chief Executive 40 Daniel Ninivaggi 40 bothof 40 Bay Biz Buzz 40 Steven Arikian 40 yr Baa3/BBB- 39 qtrly 39 Names Successor 39 http:/www.angiotech.com 39 3Q 39 BioBalance Corporation 39 2nd qtr 39 Gearoid Faherty 39 Web Site http:/www.avaya.com 39 GE Omar Ishrak 39 www.avigen.com 39 Receives URAC 39 Drew Fromkin 39 Cabrellis 39 website http:/www.BMRN.com 39 STOCKS SNAPSHOT 39 André Héroux 39 Theresa McNeely 39 CORRECTED CORRECTED 39 Armando Anido 39 Widened 39 4th qtr 39 Relations# 39 Defines 39 Accuray Incorporated 39 4Q 39 2Q 39 1Q 39 STOCKS Futures flat 39 Homebuilder Lennar posts 39 Paolo Pucci chief 39 Alegro Health 39 spokeswoman Karen Rugen 39 Robert Stanislaro 39 Berg BioMarin Pharmaceutical 39 ChiefFinancial Officer 39 David Kaysen 39 Affymax Inc. 39 Contact Anik Michaud 38 John Lute Lute 38 Media Corey Sohmer 38 4Q profit 38 Cynthia Lane clane@renmarkfinancial.com 38 nyse ABT 38 website www.BMRN.com 38 2Q profit 38 Starwatch consumer 38 Q1 opg profit 38 Tim Mayleben 38 Inc. Nasdaq AFFY 38 3rd qtr 38 STOCKS Futures rise 38 Media Barbara Lindheim 38 #Senior Vice President 38 Advanced Neuromodulation 38 Glenn L. Halpryn 38 Anders Lonner 38 #-#-#-#-# [003] 38 spokeswoman Mariann Caprino 38 www.schering plough.com 38 Lytham Partners 38 Morning Eyecatchers 38 Elias Vamvakas 38 1st qtr 38 StreetSight.net 38 PHARMACEUTICAL COMPANY 38 Networks NYSE WLP 38 Inc. Nasdaq NURO 38 Christine Cassiano 38 Q1 oper profit 38 Inc. Nasdaq EVVV 38 #-#-# KEYWORD FLORIDA 38 Dr. Ponni Subbiah 38 #Investor 38 Brinlea Johnson 38 Euroshares outlook flat 38 Elizabeth Headon 38 Roy H. Bubbs 38 William Freytag 38 http:/www.bostonscientific.com 38 spokeswoman Stacey Beckhardt 38 #Vice President 38 STOCKS Indexes 38 Verus Pharmaceuticals 38 Dale Pfost 38 Shai Gozani 38 Summary Box CVS Caremark 38 FY pretax 38 sees FY pretax 38 Neil Flanzraich 37 Dr. JW Stucki 37 #orMedia 37 www.bostonscientific.com 37 Q3 revs 37 Contact Fred Laberge 37 http:/www.vitalimages.com 37 andChief Financial 37 Q4 37 Q3 opg profit 37 REFILE INTERVIEW 37 Dec qtr 37 Bruce Cozadd 37 Andrew Uprichard 37 Krick #-#-# ext 37 3Q profit 37 trims 1Q 37 http:/www.bostonscientific.com/ 37 spokeswoman Lenore Gelb 37 Leo Benatar 37 #Director 37 visit www.cadencepharm.com 37 beats f'cast 37 Tenders Resignation 37 Joele Frank Wilkinson Brimmer 37 Aventis Pharmaceutical 37 TransPharma Medical Ltd. 37 Andre Belzile 37 FY# revs 37 Investor Relations +#-#-#-# 37 Communications# 37 FY opg 37 CONTACT Gilead Sciences 37 TESARO 37 Nasdaq DMAX 37 Broshy 37 Hans Joachim Lohrisch 37 oper profit 37 Porter Le Vay 37 H1 opg 37 pares gains 37 INSCI Corp. 37 STOCKS Futures 37 CONTACT Bobbie Volman 37 NASDAQ CGPI today 37 +#-#-#-# @ newmont.com 37 Pete Paradossi 37 Russell Fradin 37 Jesper Brandgaard 37 FOR INFORMATION CONTACT 37 Stephen K. Onody 37 Ben Leedle Jr. 37 Narrower 37 Michael Hanretta 36 EGOLI NEWS FLASH 36 Earnings Preview IAC 36 #Executive Vice 36 Jim DeCosmo 36 Elisha Finney 36 Gerri Henwood 36 Judy C. Lewent 36 Q3 36 HLSH 36 beats fcast 36 Contact Gregory FCA 36 Kathleen Heaney 36 Police Lt. Teerapop 36 Feinstein Kean Healthcare 36 www.amgen.com 36 STOCKS Indexes flat 36 Toll Brothers 4Q 36 Branislav Vajdic Ph.D. 36 Steve Sugianto 36 www.omnicare.com 36 On Call http:/www.prnewswire.com/comp/#.htmlmetastatic colorectal 36 Investor Relations# 36 Sept qtr 36 UDPATE 36 REFILE 36 Lise Hebert 36 #Senior Vice 36 Harold H. Shlevin 36 1st Ld Writethru 36 commods 36 MS Koly 36 Inc. Nasdaq RIGL 36 INDUSTRY KEYWORD TELECOMMUNICATIONS 36 Co. NYSE MMM 36 CONTACTS Investors 36 Steve DiMattia 36 NorthWest Healthcare 36 Investor Relations #-#-# x# 36 Yves Rosconi 35 Guido Neels 35 STOCKS SNAPSHOT Futures 35 H1 pretax 35 #Director Corporate 35 adj Q2 35 #-#-# @ ppdi.com 35 Q4 opg 35 Rudy Barrio 35 #/#-# KEYWORD TEXAS INDUSTRY 35 Dr. Elliot Ehrich 35 MedPointe Pharmaceuticals 35 Orbimed Advisors 35 sephraim@theruthgroup.com 35 Media Eugenia Shen 35 Ina McGuinness #-#-# 35 #Email [001] 35 Evan Pondel 35 NeuroLogica Corporation 35 Mark E. Faford 35 Masayo Tada 35 Contact Tad Hutcheson 35 STOCKS SNAPSHOT Nasdaq 35 +#-#-#-# @ cognos.com 35 Ed Trissel 35 Jack Lief 35 Nikkei pares 35 Q2 revs 35 Lars Ekman 35 STOCKS Market 35 Maribeth Landwehr 35 Alisa Steinberg 35 Seifi Ghasemi 35 INTERVIEW UPDATE 1 35 = CONTACT [002] 35 Noonan Russo 35 www.gryphongold.com 35 yr B3/B- JPM 35 michaelm@allencaron.com 35 #-#-#-# www.futuremed.ca 35 Steve Giordanella 35 Joanna Longo 35 Jason Cigarran 35 strenghtens 35 Q1 revs 35 Earnings Preview KB Home 35 acquire Omrix Biopharmaceuticals 35 spokesman Ernie Knewitz 35 #Corporate 35 Luc Mainville Chief Executive 35 beats f'casts 35 Fred Eshelman PPD 35 opg 35 Rocco Di Fruscia 35 Inc. Meg Maise 35 Ranaz Corporation 34 Vascular Intervention Guidant 34 drugstore.com inc 34 Aimee Boutcher 34 nyse BVF 34 nyse AGN 34 BioWorld International 34 Doug MacHatton 34 #-# x.# [003] 34 involves threading 34 spokesman Steven Tragash 34 #Executive 34 Medtronic Spine 34 Bob Marese 34 Cigna 2Q 34 Nick Laudico 34 DEALTALK 34 Barry Selick Threshold 34 Schlumberger 1Q 34 Laura Hortas 34 Trucker YRC 34 Reuters Messaging ryan.vlastelica.reuters.com 34 2nd Ld Writethru 34 CORRECTED 34 Sven Andreasson 34 Jay Kranzler 34 matt@allencaron.com 34 pct beats f'cast 34 CEO Alan Milinazzo 34 Sean Trauschke 34 #:# AM ET [002] 34 Allison Tomek 34 Neighborcare 34 Alexandra Tramont 34 mkt awaits 34 Lorine Sweeney 34 exec resigns 34 Chris Scalet 34 Patty Eisenhaur 34 WFD Ventures 34 Julie Loftus Trudell 34 Othera Pharmaceuticals 34 Joseph Feczko 34 andCEO 34 @ alcatel.com 34 #-# Email Website 34 SMALL MIDCAPS Stocks 34 @ pb.com 34 #Chief 34 @ pfizer.com 34 Gerald T. Proehl 34 Henri Termeer Genzyme 34 Summary Box 34 Journaliste en danger 34 Antonella Montagna 33 SKorea Hynix 33 Brainerd Communicators 33 RPT GLOBAL MARKETS 33 Dave Spigelmyer 33 RPT 33 Contacts GendeLLindheim BioCom Partners 33 Elmar Schnee 33 #.#B [006] 33 #-# bvoss@lhai.com 33 Samuel Merksamer 33 Scott Tarriff 33 Eran Broshy 33 Raymond Kerins 33 Raymond Cannefax 33 Kaydon Corporation 33 #Director Investor 33 Raghu Kilambi 33 NASDAQ MDTH 33 +#-#-#-# @ [004] 33 Pedro Lichtinger 33 Arvind Sood 33 Bob Kneeley 33 William T. Yanavitch 33 announces Instant Previews 33 METALS Copper ends 33 HL Lanzet Inc. 33 CEO Sidney Taurel 33 NEWS SAN DIEGO 33 Frank Wilkinson Brimmer 33 Brendan Intindola